Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder

por Moncrieff, Joanna, Gupta, Swapnil, Horowitz, Mark Abie
Publicado 2020

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse

por Horowitz, Mark Abie, Jauhar, Sameer, Natesan, Sridhar, Murray, Robin M, Taylor, David
Publicado 2021

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

por Horowitz, Mark Abie, Framer, Adele, Hengartner, Michael P., Sørensen, Anders, Taylor, David
Publicado 2022

Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells

por Horowitz, Mark Abie, Wertz, Jasmin, Zhu, Danhui, Cattaneo, Annamaria, Musaelyan, Ksenia, Nikkheslat, Naghmeh, Thuret, Sandrine, Pariante, Carmine Maria, Zunszain, Patricia Ana
Publicado 2015

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two sepa...

por Jørgensen, Caroline Kamp, Juul, Sophie, Siddiqui, Faiza, Horowitz, Mark Abie, Moncrieff, Joanna, Munkholm, Klaus, Hengartner, Michael Pascal, Kirsch, Irving, Gluud, Christian, Jakobsen, Janus Christian
Publicado 2023